352 related articles for article (PubMed ID: 24694640)
1. Radiotherapy for renal-cell carcinoma.
De Meerleer G; Khoo V; Escudier B; Joniau S; Bossi A; Ost P; Briganti A; Fonteyne V; Van Vulpen M; Lumen N; Spahn M; Mareel M
Lancet Oncol; 2014 Apr; 15(4):e170-7. PubMed ID: 24694640
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach.
Siva S; Kothari G; Muacevic A; Louie AV; Slotman BJ; Teh BS; Lo SS
Nat Rev Urol; 2017 Sep; 14(9):549-563. PubMed ID: 28631740
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma.
Ranck MC; Golden DW; Corbin KS; Hasselle MD; Liauw SL; Stadler WM; Hahn OM; Weichselbaum RR; Salama JK
Am J Clin Oncol; 2013 Dec; 36(6):589-95. PubMed ID: 22868242
[TBL] [Abstract][Full Text] [Related]
4. Radiation therapy in renal cell carcinoma.
De Felice F; Tombolini V
Crit Rev Oncol Hematol; 2018 Aug; 128():82-87. PubMed ID: 29958634
[TBL] [Abstract][Full Text] [Related]
5. When Surgery Is Not an Option in Renal Cell Carcinoma: The Evolving Role of Stereotactic Body Radiation Therapy.
Miccio J; Johung K
Oncology (Williston Park); 2019 May; 33(5):167-73, 177. PubMed ID: 31095714
[TBL] [Abstract][Full Text] [Related]
6. [Not Available].
Mery B; Rancoule C; Rowinski E; Bosacki C; Vallard A; Guy JB; Magné N
Bull Cancer; 2018 Dec; 105 Suppl 3():S280-S285. PubMed ID: 30595157
[TBL] [Abstract][Full Text] [Related]
7. Hypofractionated stereotactic radiotherapy and radiosurgery for the treatment of patients with radioresistant brain metastases.
Scorsetti M; Facoetti A; Navarria P; Bignardi M; De Santis M; Ninone SA; Lattuada P; Urso G; Vigorito S; Mancosu P; Del Vecchio M
Anticancer Res; 2009 Oct; 29(10):4259-63. PubMed ID: 19846983
[TBL] [Abstract][Full Text] [Related]
8. Role of Radiation in Treatment of Renal Cell Carcinoma.
Leeman JE
Hematol Oncol Clin North Am; 2023 Oct; 37(5):921-924. PubMed ID: 37246085
[TBL] [Abstract][Full Text] [Related]
9. Radiation Therapy for Patients with Advanced Renal Cell Carcinoma.
Miccio JA; Oladeru OT; Jun Ma S; Johung KL
Urol Clin North Am; 2020 Aug; 47(3):399-411. PubMed ID: 32600541
[TBL] [Abstract][Full Text] [Related]
10. [German S3 guideline for renal cell carcinoma : Presentation and discussion of essential aspects for the radiation oncologist].
Müller AC; van Oorschot B; Micke O; Guckenberger M
Strahlenther Onkol; 2018 Jan; 194(1):1-8. PubMed ID: 28819766
[TBL] [Abstract][Full Text] [Related]
11. Current Role of Radiotherapy for Renal-Cell Carcinoma: Review.
Dengina N; Tsimafeyeu I; Mitin T
Clin Genitourin Cancer; 2017 Apr; 15(2):183-187. PubMed ID: 27789182
[TBL] [Abstract][Full Text] [Related]
12. Carbon ion radiation therapy for primary renal cell carcinoma: initial clinical experience.
Nomiya T; Tsuji H; Hirasawa N; Kato H; Kamada T; Mizoe J; Kishi H; Kamura K; Wada H; Nemoto K; Tsujii H
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):828-33. PubMed ID: 18374507
[TBL] [Abstract][Full Text] [Related]
13. [The therapeutic potential of ablative radiotherapy for metastatic renal cell cancer: a tumour deemed radiation resistant].
Coucke P; Jánváry Z; Jansen N
Rev Med Liege; 2014; 69 Suppl 1():94-100. PubMed ID: 24822313
[TBL] [Abstract][Full Text] [Related]
14. Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma.
Wersäll PJ; Blomgren H; Pisa P; Lax I; Kälkner KM; Svedman C
Acta Oncol; 2006; 45(4):493-7. PubMed ID: 16760190
[No Abstract] [Full Text] [Related]
15. Stereotactic Body Radiotherapy for Kidney Cancer: Ready for Prime Time?
Carrasco-Esteban E; Barrionuevo-Castillo P; Domínguez-Rullán J; Gómez-Aparicio MA; Ferri-Molina M; Sáez-Bueno P; Zalabarría-Zarrabeitia Z; Scorsetti M; Arcangeli S; López-Campos F; Couñago F
Clin Oncol (R Coll Radiol); 2023 Mar; 35(3):163-176. PubMed ID: 36443137
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic body radiotherapy for renal cell cancer and pancreatic cancer : Literature review and practice recommendations of the DEGRO Working Group on Stereotactic Radiotherapy.
Panje C; Andratschke N; Brunner TB; Niyazi M; Guckenberger M
Strahlenther Onkol; 2016 Dec; 192(12):875-885. PubMed ID: 27778052
[TBL] [Abstract][Full Text] [Related]
17. Technique for stereotactic body radiotherapy for spinal metastases.
Foote M; Letourneau D; Hyde D; Massicotte E; Rampersaud R; Fehlings M; Fisher C; Lewis S; Macchia NL; Yu E; Laperriere NJ; Sahgal A
J Clin Neurosci; 2011 Feb; 18(2):276-9. PubMed ID: 21147535
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of ablative high-dose-per-fraction radiation for implanted human renal cell cancer in a nude mouse model.
Walsh L; Stanfield JL; Cho LC; Chang CH; Forster K; Kabbani W; Cadeddu JA; Hsieh JT; Choy H; Timmerman R; Lotan Y
Eur Urol; 2006 Oct; 50(4):795-800; discussion 800. PubMed ID: 16632182
[TBL] [Abstract][Full Text] [Related]
19. Phase 1 study of stereotactic body radiotherapy and interleukin-2--tumor and immunological responses.
Seung SK; Curti BD; Crittenden M; Walker E; Coffey T; Siebert JC; Miller W; Payne R; Glenn L; Bageac A; Urba WJ
Sci Transl Med; 2012 Jun; 4(137):137ra74. PubMed ID: 22674552
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic Body Radiotherapy for Large Primary Renal Cell Carcinoma.
Kaidar-Person O; Price A; Schreiber E; Zagar TM; Chen RC
Clin Genitourin Cancer; 2017 Oct; 15(5):e851-e854. PubMed ID: 28462856
[No Abstract] [Full Text] [Related]
[Next] [New Search]